Older woman develops recurrent syncope soon after starting acamprosate; extensive cardiac and neurologic evaluation is negative and symptoms resolve after discontinuation.

Please provide your email address to receive an email when new articles are posted on . Injectable naltrexone showed a more favorable safety profile than its oral counterpart and other alcohol use ...

WASHINGTON -- Acamprosate (Campral) was safe to use in people with liver disease, a phase II study showed. Among people with alcohol use disorder (AUD) and alcohol-associated liver disease, ...

Male Wistar rats (Charles River), weighing between 250 and 300 g at the beginning of the experiments, were employed. Rats were housed in groups of three in a temperature- and humidity-controlled ...

September 13, 2010 — Acamprosate appears to be effective and safe for supporting continuous abstinence after detoxification in alcohol-dependent patients, according to the results of a systematic ...

Acamprosate reduces the number of patients being treated for alcoholism who return to drinking, according to a new review. The drug showed moderate benefits in trials when used in addition to non-drug ...

Please provide your email address to receive an email when new articles are posted on . The numbers needed to treat to prevent return to any drinking were 11 for acamprosate and 18 for oral naltrexone ...

Acamprosate is a medication used in Europe and elsewhere to prevent relapse in alcoholics. New findings, in conjunction with previous research, indicate that acamprosate should be safe to take when ...

Acamprosate is used to treat alcohol dependence along with other rehabilitation therapy such as counseling and social support in people who have the intention of avoiding alcohol consumption.

Dublin, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The "Acamprosate (CAS 77337-76-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ...